OIM

Oracle Investment Management Portfolio holdings

AUM $116M
This Quarter Return
-1.12%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$752M
AUM Growth
+$752M
Cap. Flow
+$26.4M
Cap. Flow %
3.51%
Top 10 Hldgs %
98.49%
Holding
16
New
–
Increased
7
Reduced
3
Closed
–

Top Buys

1
AGEN
Agenus
AGEN
$25.6M
2
OPK icon
Opko Health
OPK
$4.83M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4.1M
4
PACB icon
Pacific Biosciences
PACB
$3.96M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
$1.81M

Top Sells

1
AWH
Aspira Women's Health Inc. Common Stock
AWH
$5.06M
2
AMRN
Amarin Corp
AMRN
$4.85M
3
QDEL icon
QuidelOrtho
QDEL
$4.53M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.95B
$394M 51.91%
1,795,462
-20,632
-1% -$4.53M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$135M 17.77%
2,074,800
+63,100
+3% +$4.1M
AGEN
3
Agenus
AGEN
$133M
$52.5M 6.92%
13,134,900
+6,412,440
+95% +$25.6M
OPK icon
4
Opko Health
OPK
$1.1B
$49.3M 6.49%
13,355,773
+1,309,887
+11% +$4.83M
AXDX
5
DELISTED
Accelerate Diagnostics
AXDX
$43.6M 5.75%
4,091,749
+22,807
+0.6% +$243K
AWH
6
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$26.7M 3.52%
8,647,774
-1,640,813
-16% -$5.06M
PACB icon
7
Pacific Biosciences
PACB
$393M
$17M 2.24%
1,721,459
+401,100
+30% +$3.96M
SLNO icon
8
Soleno Therapeutics
SLNO
$3.6B
$9.21M 1.21%
3,670,384
– –
BCRX icon
9
BioCryst Pharmaceuticals
BCRX
$1.74B
$8.68M 1.14%
2,525,857
+525,857
+26% +$1.81M
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
$4.59M 0.6%
1,699,566
– –
AMRN
11
Amarin Corp
AMRN
$311M
$4.28M 0.56%
1,015,501
-1,152,641
-53% -$4.85M
MOTS
12
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$3.72M 0.49%
3,806,666
– –
BIIB icon
13
Biogen
BIIB
$19.4B
$1.05M 0.14%
3,688
– –
YMAB icon
14
Y-mAbs Therapeutics
YMAB
$388M
$968K 0.13%
25,212
– –
CFRX
15
DELISTED
ContraFect Corporation
CFRX
$885K 0.12%
167,587
+38,742
+30% +$205K
BIOL
16
DELISTED
Biolase, Inc.
BIOL
$478K 0.06%
1,739,100
– –